About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01423383

Epidemiology Study of Keloid

Although keloid is a very common condition; there are no statistics as to its true incidence and prevalence, neither in United States, nor elsewhere in the world. This trial intends to capture epidemi...

Lead sponsor: Tirgan, Michael H., M.D.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Michael H. Tirgan, MD

CONTACT

(212) 874 4200 htirgan@aol.com

Sponsors

Lead Sponsor

Tirgan, Michael H., M.D.

The purpose of current trial is to establish a robust database of incidence and prevalence of keloid, as well as prevalence of familial keloid, in various ethnic groups. Study sample size is 100,000 random individuals who will fill out either a web survery or a paper questionnaire.

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Informed consent
•2. Age above 18 to answer the survey questions
•3. Parents shall respond on behalf of their minor children

Exclusion Criteria

•None

Related studies

RECRUITINGPhase 3

Topical Cryotherapy and Keloid/Hypertrophic Scars

NCT07336368 · Keloid Scars, Hypertrophic Scars

RECRUITINGPhase 2

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

NCT06373458 · Keloid

Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry

NCT06806735 · Keloid Scar Following Surgery, Scars, Hypertrophic, and more

Enrolling By InvitationNA

Preoperative Silicone Ointment and Wound Healing

NCT05461157 · Wound Heal, Scar, and more

Active Not RecruitingPhase 4

Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.

NCT07014280 · Keloids

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 18, 2016Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment100,000

Start dateSep 2011

Last updatedOct 18, 2016

Condition

Locations shown

Michael H. Tirgan, MD

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 18, 2016Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions